LEXINGTON, Mass., March 28, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company will report its fourth quarter 2024 financial and...
Hence then, the article about curis to report fourth quarter 2024 financial and operating results and host conference call and webcast on march 31 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025 )
Also on site :
- Timothee Chalamet Shows Subtle Support for Girlfriend Kylie Jenner
- From collapse fears to resilience: How Russia reshaped its economy by the end of 2025
- Russian MOD shows map of Ukrainian drone attack on Putin’s residence